e-7564
August 5, 2026
Fund Elahere nationally
Helena Jaczek · 1,155 signatures
Petitioners ask the Minister of Health to instruct the pCPA to restart negotiations with AbbVie and reach a pan‑Canadian funding agreement making Elahere (mirvetuximab soravtansine) a funded treatment for ovarian, fallopian tube and peritoneal cancers.